Mirae Asset Global ETFs Holdings’s MaxCyte MXCT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$33.8K	Buy	48,084 +1,156	+2%	+$1.08K	﹤0.01%	2978
2025 Q4	$72.7K	Sell	46,928 -554	-1%	-$885	﹤0.01%	2809
2025 Q3	$75K	Sell	47,482 -7,857	-14%	-$13.7K	﹤0.01%	2801
2025 Q2	$121K	Sell	55,339 -7,242	-12%	-$17.5K	﹤0.01%	2511
2025 Q1	$171K	Buy	62,581 +2,652	+4%	+$10.5K	﹤0.01%	2399
2024 Q4	$249K	Buy	59,929 +2,584	+5%	+$9.77K	﹤0.01%	2268
2024 Q3	$223K	Buy	57,345 +13,416	+31%	+$56.5K	﹤0.01%	2322
2024 Q2	$172K	Buy	+43,929	New	+$189K	﹤0.01%	2328

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $88.9M AUM

Mirae Asset Global ETFs Holdings's MXCT Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its MaxCyte (MXCT) stake by 2.5% in Q1 2026, buying an estimated $1.08K and bringing the position to 48,084 shares worth $33.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2978.

Mirae Asset Global ETFs Holdings first reported a position in MXCT in Q2 2024 and has held it in 8 quarters since. The position peaked at $249K in Q4 2024. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

Mirae Asset Global ETFs Holdings held 48,084 shares of MaxCyte worth $33.8K as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 1,156 MaxCyte shares in Q1 2026, an estimated $1.08K.
MaxCyte made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2978 holding.
Mirae Asset Global ETFs Holdings first reported a position in MaxCyte in Q2 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's MaxCyte position peaked at $249K in Q4 2024.
130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.